Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis

被引:218
作者
Manetti, Mirko [1 ]
Romano, Eloisa [2 ]
Rosa, Irene [1 ,2 ]
Guiducci, Serena
Bellando-Randone, Silvia [2 ]
De Paulis, Amato [3 ,4 ]
Ibba-Manneschi, Lidia [1 ]
Matucci-Cerinic, Marco [2 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, Sect Anat & Histol, Largo Brambilla 3, I-50134 Florence, Italy
[2] Univ Florence, AOUC, Dept Expt & Clin Med, Sect Internal Med,Rheumatol Unit, Florence, Italy
[3] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[4] Univ Naples Federico II, Ctr Basic & Clin Immunol Res, Naples, Italy
关键词
PLASMINOGEN-ACTIVATOR RECEPTOR; CHRONIC KIDNEY-DISEASE; PULMONARY-FIBROSIS; IN-VITRO; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; FLI1; DEFICIENCY; RENAL FIBROSIS; GROWTH-FACTOR; CELLS;
D O I
10.1136/annrheumdis-2016-210229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Systemic sclerosis (SSc) features multiorgan fibrosis orchestrated predominantly by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a transdifferentiation by which endothelial cells (ECs) lose their specific morphology/markers and acquire myofibroblast-like features. Here, we determined the possible contribution of EndoMT to the pathogenesis of dermal fibrosis in SSc and two mouse models. Methods Skin sections were immunostained for endothelial CD31 or vascular endothelial (VE)-cadherin in combination with a-smooth muscle actin (a-SMA) myofibroblast marker. Dermal microvascular ECs (dMVECs) were prepared from SSc and healthy skin (SSc-dMVECs and H-dMVECs). H-dMVECs were treated with transforming growth factor-a1 (TGFa1) or SSc and healthy sera. Endothelial/mesenchymal markers were assessed by real-time PCR, immunoblotting and immunofluorescence. Cell contractile phenotype was assayed by collagen gel contraction. Results Cells in intermediate stages of EndoMT were identified in dermal vessels of either patients with SSc or bleomycin-induced and urokinase-type plasminogen activator receptor (uPAR)-deficient mouse models. At variance with H-dMVECs, SSc-dMVECs exhibited a spindle-shaped appearance, co-expression of lower levels of CD31 and VE-cadherin with myofibroblast markers (alpha-SMA+ stress fibres, S100A4 and type I collagen), constitutive nuclear localisation of the EndoMT driver Snail1 and an ability to effectively contract collagen gels. Treatment of H-dMVECs either with SSc sera or TGFa1 resulted in the acquisition of a myofibroblast-like morphology and contractile phenotype and downregulation of endothelial markers in parallel with the induction of mesenchymal markers. Matrix metalloproteinase-12-dependent uPAR cleavage was implicated in the induction of EndoMT by SSc sera. Conclusions In SSc, EndoMT may be a crucial event linking endothelial dysfunction and development of dermal fibrosis.
引用
收藏
页码:924 / 934
页数:11
相关论文
共 50 条
[1]   Systemic sclerosis [J].
Allanore, Yannick ;
Simms, Robert ;
Distler, Oliver ;
Trojanowska, Maria ;
Pope, Janet ;
Denton, Christopher P. ;
Varga, John .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]  
ARCINIEGAS E, 1992, J CELL SCI, V103, P521
[3]   Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy [J].
Asano, Yoshihide ;
Stawski, Lukasz ;
Hant, Faye ;
Highland, Kristin ;
Silver, Richard ;
Szalai, Gabor ;
Watson, Dennis K. ;
Trojanowska, Maria .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (04) :1983-1998
[4]   Urokinase receptor cleavage: A crucial step in 14 fibroblast-to-myofibroblast differentiation [J].
Bernstein, Audrey M. ;
Twining, Sally S. ;
Warejcka, Debra J. ;
Tall, Edward ;
Masur, Sandra K. .
MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (07) :2716-2727
[5]   Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide [J].
Borghini, Annalisa ;
Manetti, Mirko ;
Nacci, Francesca ;
Bellando-Randone, Silvia ;
Guiducci, Serena ;
Matucci-Cerinic, Marco ;
Ibba-Manneschi, Lidia ;
Weber, Elisabetta .
PLOS ONE, 2015, 10 (06)
[6]   Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis [J].
Cabral-Marques, Otavio ;
Riemekasten, Gabriela .
AUTOIMMUNITY REVIEWS, 2016, 15 (07) :690-694
[7]   Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease [J].
Charytan, David M. ;
Padera, Robert ;
Helfand, Alexander M. ;
Zeisberg, Michael ;
Xu, Xingbo ;
Liu, Xiaopeng ;
Himmelfarb, Jonathan ;
Cinelli, Angeles ;
Kalluri, Raghu ;
Zeisberg, Elisabeth M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (01) :99-109
[8]   Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis [J].
Distler, Joerg H. W. ;
Juengel, Astrid ;
Huber, Lars C. ;
Schulze-Horsel, Ursula ;
Zwerina, Jochen ;
Gay, Renate E. ;
Michel, Beat A. ;
Hauser, Thomas ;
Schett, Georg ;
Gay, Steffen ;
Distler, Oliver .
ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :311-322
[9]   Origin of fibrosing cells in systemic sclerosis [J].
Ebmeier, Sarah ;
Horsley, Valerie .
CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (06) :555-562
[10]   Mechanisms of Disease: Scleroderma. [J].
Gabrielli, Armando ;
Avvedimento, Enrico V. ;
Krieg, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (19) :1989-2003